Does ROSUVASTATIN Cause Dermatitis exfoliative generalised? 14 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 14 reports of Dermatitis exfoliative generalised have been filed in association with ROSUVASTATIN (Rosuvastatin Calcium). This represents 0.0% of all adverse event reports for ROSUVASTATIN.
14
Reports of Dermatitis exfoliative generalised with ROSUVASTATIN
0.0%
of all ROSUVASTATIN reports
0
Deaths
14
Hospitalizations
How Dangerous Is Dermatitis exfoliative generalised From ROSUVASTATIN?
Of the 14 reports, 14 (100.0%) required hospitalization, and 8 (57.1%) were considered life-threatening.
Is Dermatitis exfoliative generalised Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ROSUVASTATIN. However, 14 reports have been filed with the FAERS database.
What Other Side Effects Does ROSUVASTATIN Cause?
Myalgia (3,958)
Dyspnoea (2,832)
Pain (2,758)
Drug ineffective (2,347)
Fatigue (2,208)
Rhabdomyolysis (2,173)
Arthralgia (1,879)
Asthma (1,843)
Muscle spasms (1,843)
Pain in extremity (1,686)
What Other Drugs Cause Dermatitis exfoliative generalised?
ALLOPURINOL (192)
DUPILUMAB (162)
METHOTREXATE (151)
SULFAMETHOXAZOLE\TRIMETHOPRIM (140)
AMOXICILLIN (122)
ADALIMUMAB (113)
PANTOPRAZOLE (105)
SECUKINUMAB (96)
VANCOMYCIN (92)
AMLODIPINE (91)
Which ROSUVASTATIN Alternatives Have Lower Dermatitis exfoliative generalised Risk?
ROSUVASTATIN vs ROSUVASTATIN\ROSUVASTATIN
ROSUVASTATIN vs ROTIGOTINE
ROSUVASTATIN vs ROXADUSTAT
ROSUVASTATIN vs ROXICODONE
ROSUVASTATIN vs ROXITHROMYCIN